Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study

Publication files not online:

Author: Brink, M. · Goeij, A.F.P.M. de · Weijenberg, M.P. · Roemen, G.M.J.M. · Lentjes, M.H.F.M. · Pachen, M.M.M. · Smits, K.M. · Bruïne, A.P. de · Goldbohm, R.A. · Brandt, P.A. van den
Type:article
Date:2003
Source:Carcinogenesis, 4, 24, 703-710
Identifier: 237017
doi: doi:10.1093/carcin/bgg009
Keywords: Health Biology · Food and Chemical Risk Analysis · adenine · DNA fragment · guanine · thymine · adult · aged · cancer cell culture · cancer growth · cancer localization · cancer risk · cancer staging · cancer tissue · codon · cohort analysis · colon carcinogenesis · colorectal cancer · controlled study · correlation analysis · DNA purification · environmental factor · exon · familial cancer · family history · female · gene mutation · gene sequence · histopathology · human · human cell · human tissue · incidence · major clinical study · male · mutational analysis · Netherlands · nucleic acid base substitution · oncogene K ras · polymerase chain reaction · priority journal · reproducibility · review · tumor biopsy · tumor differentiation · validation process · Base Sequence · Cohort Studies · Colorectal Neoplasms · DNA Primers · Genes, ras · Humans · Mutation · Netherlands

Abstract

Activation of K-ras oncogene has been implicated in colorectal carcinogenesis, being mutated in 30-60% of the adenocarcinomas. In this study, 737 incident colorectal cancer (CRC) patients, originating from 120 852 men and women (55-69 years at baseline) participating in the Netherlands Cohort Study (NLCS), were studied in order to evaluate subgroups with respect to K-ras mutation status. Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29, was performed on archival colorectal adenocarcinoma samples of all patients using macrodissection, nested PCR and direct sequencing of purified fragments. The method of mutation detection was validated by the confirmation of reported K-ras status in CRC cell lines, a good correlation between fresh-frozen and routinely fixed, paraffin-embedded tissue, a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras mutations were evaluated with respect to tumour sub-localization, Dukes' stage and tumour differentiation. In 37% (271/737) of the patients the exon 1 fragment of K-ras gene was found to be mutated The predominant mutations are G>A transitions and G>T transversions, and codons 12 and 13 are the most frequently affected codons. Patients with a rectal tumour were found to have the highest frequency of G>T transversions as compared with patients with a colon or rectosigmoid tumour. This difference appeared to be confined to women with a rectal tumour harbouring G>T transversions. No significant differences were observed for Dukes' stage with respect to types of K-ras mutation, which does not support direct involvement of the K-ras oncogene in adenocarcinoma progression. The equal distribution of K-ras mutations among cases with or without a family history of colorectal cancer argues against an important role for this mutation in familial colorectal cancer, and could imply that K-ras mutations are more probably involved in environmental mechanisms of colorectal carcinogenesis.